Papers on elamipretide
138 papers1 new in 30 days
Saturday, February 18
Friday, February 3
bioRxiv
Elamipretide Improves ADP Sensitivity in Aged Mitochondria by Increasing Uptake through the Adenine Nucleotide Translocator (ANT)
Preprint: experiments in animalsElamipretide
Saturday, January 7
Journal of Neuroinflammation
Elamipretide alleviates pyroptosis in traumatically injured spinal cord by inhibiting cPLA2-induced lysosomal membrane permeabilization
Experiments in miceElamipretide
Thursday, December 1
Friday, November 18
Scientific Reports
Beneficial effects of SS-31 peptide on cardiac mitochondrial dysfunction in tafazzin knockdown mice
Experiments in miceElamipretide
Saturday, November 12
Wednesday, November 2
GeroScience
Elamipretide effects on the skeletal muscle phosphoproteome in aged female mice
Experiments in miceElamipretide
Friday, October 7
Biomedicine & Pharmacotherapy
Skeletal muscle mitochondrial remodeling in heart failure: An update on mechanisms and therapeutic opportunities
ReviewMitochondrion
Friday, September 30
Aging Pathobiology and Therapeutics
Long-term treatment with Elamipretide enhances healthy aging phenotypes in mice
Experiments in miceElamipretide
Friday, September 16
Thursday, July 21
The American Journal of Sports Medicine
Evaluation of SS-31 as a Potential Strategy for Tendinopathy Treatment: An In Vitro Model
Experiments in human cellsElamipretide
Monday, June 6
Oxidative Medicine and Cellular Longevity
SS-31, a Mitochondria-Targeting Peptide, Ameliorates Kidney Disease
ReviewElamipretide
Thursday, April 14
Monday, February 21
Disease Models & Mechanisms
Treatment of age-related visual impairment with a peptide acting on mitochondria
Experiments in miceEye
Monday, January 17
Frontiers in Integrative Neuroscience
Neuroprotective Effects of a Small Mitochondrially-Targeted Tetrapeptide Elamipretide in Neurodegeneration
ReviewElamipretide
Wednesday, December 1
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
Protective effect of mitochondria-targeted antioxidant peptide SS-31 in sepsis-induced acute kidney injury
Experiments in 60 miceElamipretide
Saturday, November 27
Ophthalmology Science
Phase 1 Clinical Trial of Elamipretide in Dry Age-Related Macular Degeneration and Noncentral Geographic Atrophy: ReCLAIM NCGA Study
Non-randomized trial in 19 peopleElamipretide
Saturday, September 4
Thursday, July 22
Saturday, July 17
Heart Failure Reviews
Current and emerging drug targets in heart failure treatment
ReviewHeart failure
Thursday, July 15
Wednesday, May 26
Neurobiology of Aging
Visit-to-visit blood pressure variability and regional cerebral perfusion decline in older adults
Cohort study in peopleBlood pressure variability
Saturday, May 22
BMC Research Notes
The effects of a mitochondrial targeted peptide (elamipretide/SS31) on BAX recruitment and activation during apoptosis
Experiments in human cellsElamipretide
Tuesday, April 13
Oxidative Medicine and Cellular Longevity
SS-31 Protects Liver from Ischemia-Reperfusion Injury via Modulating Macrophage Polarization
Experiments in animalsElamipretide
Monday, March 1
Frontiers in Aging Neuroscience
Elamipretide (SS-31) Improves Functional Connectivity in Hippocampus and Other Related Regions Following Prolonged Neuroinflammation Induced by Lipopolysaccharide in Aged Rats
Experiments in ratsElamipretide
Thursday, February 18
Thursday, February 11
Biochemical and Biophysical Research Communications
SS-31 ameliorates hepatic injury in rats subjected to severe burns plus delayed resuscitation via inhibiting the mtDNA/STING pathway in Kupffer cells
Experiments in ratsElamipretide